Key Highlights

  • Lakewood-Amedex Biotherapeutics (NASDAQ:LABT) changed hands on roughly 351 million shares as it jumped 290.33% to USD 0.7471 after redeeming all of its Series C preferred stock.
  • Baird Medical Investment Holdings Limited (NASDAQ:BDMD) traded roughly 108.64 million shares and gained 20.26% despite a Nasdaq bid price letter.
  • Zeta Network Group (NASDAQ:ZNB) surged 73.7% on around 61.08 million shares, with cash of about USD 44,000 as of June 30, 2026.
  • Elong Power Holding Limited (NASDAQ:ELPW) advanced 44.31% on about 46.71 million shares following a framework deal worth at least RMB 2 billion.

Lakewood-Amedex Biotherapeutics (NASDAQ:LABT): 351 Million Shares Change Hands

Lakewood-Amedex Biotherapeutics (NASDAQ:LABT) leads the Volume table with about 351 million shares traded, alongside a 290.33% gain to USD 0.7471 during trading on November 5, 2026, based on published quotes. At 8:02 a.m. ET that day the company announced it had finished redeeming all 127,097 remaining Series C Preferred Shares for USD 1,270,970 in cash, under an agreement dated November 2, 2026 with Shakawe Capital LLC. The payment works out to USD 10 per preferred share, a simple calculation from two published numbers. Management says no preferred stock and no borrowed-money Debt remain outstanding. The market reads it this way: convertible preferred can turn into common shares at a discount, so retiring it removes a source of future selling and dilution. The trade-off is cash, since the money paid for the Redemption may shorten the runway of a clinical-stage company that has no product Revenue described here. Filings from August and September 2026 are mentioned in published coverage, and Market Value figures conflict across pages and are omitted. The risks are reduced runway, future dilution, a thin float and clinical results, and a quoted move of this size can reverse quickly.

Baird Medical Investment Holdings Limited (NASDAQ:BDMD): 108.64 Million Shares and a Bid Price Letter

Baird Medical Investment Holdings Limited (NASDAQ:BDMD) ranks second by volume, with about 108.64 million shares traded as the stock gained 20.26% to USD 0.1312 during trading on November 5, 2026, based on published quotes. The spotlight falls on a Nasdaq minimum bid price deficiency letter dated November 2, 2026 and announced November 4, 2026. The company has 180 calendar days, through May 3, 2027, to restore a closing bid of USD 1.00 for at least ten consecutive Business days. That bar sits more than seven times above the current quote, a simple calculation. On November 4, 2026 the company stated it knew of no material development or undisclosed reason behind its recent share price decline, which means the volume is not tied to any announced business event. No financial results were located and no reverse split has been announced. Heavy turnover in a sub-dollar stock often reflects speculative trading rather than new information, and it can unwind as quickly as it built. If the bid stays low, a reverse split or delisting proceedings could follow, and a split often brings dilution. Published market data puts the market value near USD 4.2 million.

Zeta Network Group (NASDAQ:ZNB): 61 Million Shares on Unconfirmed AI Coverage

Zeta Network Group (NASDAQ:ZNB) jumped 73.7% to USD 1.0804 during trading on November 5, 2026, based on published quotes, on volume of about 61.08 million shares. Published coverage tied the move to an expansion in AI infrastructure, a single-source claim that remains unconfirmed. The latest filing is the fiscal 2026 Annual Report on Form 20-F covering the year to June 30, 2026. It shows revenue of about USD 28.4 million, up 225%, but a net loss of about USD 157.5 million, including a USD 114.0 million Impairment on SolvBTC. Cash stood at about USD 44,000, and management says there is substantial doubt about the company's ability to keep operating as a going concern. The company executed a 100-for-1 reverse split on March 12, 2026 and an 8-for-1 reverse split on July 27, 2026, and holds notes of up to USD 10 million, with a first close of USD 6 million. A Going Concern warning means the company may be unable to fund operations for a year without new capital, which usually means new shares. A 73.7% rise on heavy volume in a nano-cap can reverse sharply, and crypto exposure adds volatility.

Elong Power Holding Limited (NASDAQ:ELPW): 46.71 Million Shares on a Framework Deal

Elong Power Holding Limited (NASDAQ:ELPW) advanced 44.31% to USD 3.62 during trading on November 5, 2026, based on published quotes, on volume of about 46.71 million shares. The company revealed a three-year cooperation agreement that calls for purchases of at least RMB 2 billion, about USD 300 million, of energy storage equipment. A first purchase contract of at least RMB 300 million, about USD 45 million, is slated for signing in January 2027. These are intentions rather than signed orders, and the counterparty is unnamed. A framework agreement sets terms for future buying but does not guarantee it. Published market data puts the market value near USD 3.38 million, a fraction of the headline contract value, which explains part of the excitement and also why caution is warranted. The company had announced a USD 25.5 million distribution agreement on October 28, 2026, and sold its lithium battery Subsidiary in March 2026. First-half revenue was USD 2.9 million, margins were described as near zero in published coverage, and a 1-for-45 reverse split took effect August 10, 2026. Dilution and Reversal risk apply.

Fly-E Group, Inc. (NASDAQ:FLYE): 22.85 Million Shares on Heavy Volume

Fly-E Group, Inc. (NASDAQ:FLYE) ranks last in the volume list with 22.85 million shares traded as the stock climbed 30.58% to USD 2.22 during trading on November 5, 2026, based on published quotes. No filing from the same day explaining the volume has been identified. The most recent major update is fiscal 2026 results released July 24, 2026, along with a Nasdaq listing notice whose reason has not been reviewed. Net revenues fell 25.0% to USD 19.1 million from USD 25.4 million, gross Margin slid to 24.4% from 41.1%, and the net loss widened to USD 9.3 million from USD 5.3 million, or USD 8.38 per share. Cash at March 31, 2026 was USD 0.3 million, down from USD 0.8 million. Strong turnover paired with weak financials is a mismatch that tends to resolve through price, and quoted gains can reverse. A company with little cash may sell new shares, and heavy volume can give it an opening. Store closures, listing notices and dilution are the named risks. Quarterly results after fiscal 2026 were not retrieved, and the details of any reverse splits were not found.

Where Things Stand

The heaviest volume on November 5, 2026 landed on nano-cap and micro-cap names where activity ran ahead of verified information: a preferred redemption, a bid price letter, unconfirmed AI coverage, a framework deal and an unexplained spike. The overall picture is weak, because volume measures attention rather than fundamentals, and every move here can reverse. Lakewood-Amedex Biotherapeutics (NASDAQ:LABT) has the clearest catalyst in a filed redemption. Baird Medical Investment Holdings Limited (NASDAQ:BDMD) faces a compliance deadline of May 3, 2027. Zeta Network Group (NASDAQ:ZNB) carries a going concern warning. Elong Power Holding Limited (NASDAQ:ELPW) rests on unsigned purchases. Fly-E Group, Inc. (NASDAQ:FLYE) has little cash. Watch confirmation, funding and dilution as the next items.